Sales Growth YoY (Last 12 Months): sonnetbio.com (SONN)

Public company logo of sonnetbio.com (SONN)

The use of AI protein modeling has strengthened the professional image of Sonnet BioTherapeutics (SONN) within the targeted cytokine niche. The trailing 12-month sales growth relative to the previous year illustrates this process, where the 1697.80 level represents the current value. However, the absence of commercial products and a reliance on external capital render the company's financial position unstable.

Sonnet BioTherapeutics Holdings Inc. (SONN) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 12/13/2025

Sonnet BioTherapeutics (SONN) - metric breakdowns and financial figures

- market price and analyst price targets:
Summary company analytics:Sonnet BioTherapeutics
Product sample of Sonnet BioTherapeutics Holdings Inc.

The virtual model of Sonnet BioTherapeutics (SONN) utilizing R&D outsourcing makes the company dependent on the efficiency of external contractors. This indicator calculates the percentage change in revenue over a rolling year, neutralizing seasonal fluctuations. The metric allows for an assessment of the business's real operational expansion from a fundamental perspective. Investors should keep in mind that even a positive trend does not guarantee capital protection during a cycle shift. By analyzing the TTM revenue growth rate compared to the previous year, one can judge the scalability of the current strategy.

Competitors of Sonnet BioTherapeutics (SONN)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|ALX Oncology (ALXO) - Trailing Twelve Months Revenue Growth|CUE: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth PDSB|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)